Tests:Alpha Fetoprotein, Tumor Marker: Difference between revisions
Tests:Alpha Fetoprotein, Tumor Marker
No edit summary |
|||
| (11 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
{{DISPLAYTITLE: Alpha Fetoprotein | {{DISPLAYTITLE: Alpha Fetoprotein (Tumor Marker)}} | ||
[[Category:Tests]] | [[Category:Tests]] | ||
[[Category:Biochemistry]] | [[Category:Biochemistry]] | ||
| Line 5: | Line 5: | ||
{| class="wikitable" | {| class="wikitable" | ||
! colspan="2" | | ! colspan="2" | | ||
== Overview == | |||
|- | |- | ||
|Department | |Department | ||
|Biochemistry | |Biochemistry | ||
|- | |- | ||
|Test Code | |Test Code | ||
| Line 14: | Line 14: | ||
|- | |- | ||
|Synonyms | |Synonyms | ||
|Tumour Marker (AFP) | |Tumour Marker (AFP) | ||
AFP (tumour marker) | |||
AFP (tumour marker) | |- | ||
|Availability | |||
|Performed Mon-Fri. Available out of hours except weekends and public holidays | |||
|- | |- | ||
|Turnaround Time | |Turnaround Time | ||
|1 hour to 3 days. | |1 hour to 3 days. | ||
|- | |- | ||
! colspan="2" | | |Stability – Add test | ||
|24 hours | |||
|- | |||
! colspan="2" | | |||
== Specimen Requirements == | |||
|- | |- | ||
|Specimen | |Specimen | ||
| | |Serum | ||
|- | |- | ||
|Preferred | |Preferred | ||
| | |Plain Yellow-top or <span style="background:#e30022"> Red-Top </span> tube | ||
|- | |- | ||
|Acceptable | |Acceptable | ||
| | |Plain Yellow-top or <span style="background:#e30022"> Red-Top </span> tube | ||
|- | |||
|Unacceptable | |||
|Plasma samples | |||
|- | |||
|Paediatric Requirements | |||
|0.5 mL paediatric <span style="background:#e30022">Red-Top </span> | |||
|- | |- | ||
| | ! colspan="2" | | ||
== Aliquot Requirements == | |||
|- | |- | ||
|Sample | |||
|Serum | |||
|- | |- | ||
| | |Preferred Volume | ||
| | |>500 µL | ||
|- | |- | ||
|Minimum Volume | |Minimum Volume | ||
|200 µL | |200 µL | ||
|- | |- | ||
|Aliquot Transportation | |Aliquot Transportation | ||
| | | | ||
|- | |- | ||
! colspan="2" |== Clinical Information == | |||
! colspan="2" | | |||
|- | |- | ||
|Reference Intervals | |Reference Intervals | ||
| Line 57: | Line 67: | ||
|- | |- | ||
|Test Method | |Test Method | ||
| | |Abbott Alinity CI analyser , Abbott Reagent. | ||
|- | |- | ||
|Advanced Notice | |Advanced Notice | ||
|Not | |Not required | ||
|- | |||
|Patient Preparation | |||
|Not required | |||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
== Comments == | |||
|- | |- | ||
| colspan="2" | This test is useful as a tumour marker and as a safe and effective supplement to the management of patients undergoing treatment for non-seminomatous testicular cancer and | | colspan="2" | This test is useful as a tumour marker and as a safe and effective supplement to the management of patients undergoing treatment for non-seminomatous testicular cancer and | ||
certain germ cell cancers, or for patients being monitored after therapy is complete. | |||
The test is NOT a screening test for cancer. | |||
The test is NOT intended as a screen for neural tube defects. | The test is NOT intended as a screen for neural tube defects. | ||
| Line 72: | Line 87: | ||
For the serial monitoring of tumours, tumour markers should be tested in the same laboratory. | For the serial monitoring of tumours, tumour markers should be tested in the same laboratory. | ||
|} | |} | ||
{{DocMeta | |||
| owner = Crossley1 | |||
| review_ping = | |||
}} | |||
Latest revision as of 19:51, 14 September 2026
Overview | |
|---|---|
| Department | Biochemistry |
| Test Code | TAFP |
| Synonyms | Tumour Marker (AFP)
AFP (tumour marker) |
| Availability | Performed Mon-Fri. Available out of hours except weekends and public holidays |
| Turnaround Time | 1 hour to 3 days. |
| Stability – Add test | 24 hours |
Specimen Requirements | |
| Specimen | Serum |
| Preferred | Plain Yellow-top or Red-Top tube |
| Acceptable | Plain Yellow-top or Red-Top tube |
| Unacceptable | Plasma samples |
| Paediatric Requirements | 0.5 mL paediatric Red-Top |
Aliquot Requirements | |
| Sample | Serum |
| Preferred Volume | >500 µL |
| Minimum Volume | 200 µL |
| Aliquot Transportation | |
| == Clinical Information == | |
| Reference Intervals | 0 - 16 µg/L (non-pregnant)
See comment |
| Test Method | Abbott Alinity CI analyser , Abbott Reagent. |
| Advanced Notice | Not required |
| Patient Preparation | Not required |
Comments | |
| This test is useful as a tumour marker and as a safe and effective supplement to the management of patients undergoing treatment for non-seminomatous testicular cancer and
certain germ cell cancers, or for patients being monitored after therapy is complete. The test is NOT a screening test for cancer. The test is NOT intended as a screen for neural tube defects. For the serial monitoring of tumours, tumour markers should be tested in the same laboratory. | |
| Owner | Clair Crossley (Crossley1) |
|---|---|
| Last reviewed | 14.09.2026 |
| Next review | 14.09.2027 (OK) |